CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 464 enrolled
Drug / intervention
Direct-to-patient tailored cardiovascular risk message systembehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01286311
NCT01286311N/ACompleted

Tailored Communication to Reduce Cardiovascular Risk

Northwestern University·interventional·Posted Jan 31, 2011·Updated Feb 9, 2015

In Brief

A clinical study evaluating Direct-to-patient tailored cardiovascular risk message system for Hypercholesterolemia and 3 related conditions. Completed, enrolled 464 participants across 1 site.

Detailed Summary

The primary goal of the trial is to test the feasibility and efficacy of a cardiovascular disease quality improvement system that couples EMR-based patient identification with individually tailored patient messages. The study will test the hypothesis that that a tailored patient-directed approach to cardiovascular risk reduction integrated into patients' primary care delivery site will improve control of elevated low-density lipoprotein cholesterol and other card iac risk factors more than routine care alone for patients at intermediate or high risk for cardiovascular disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 31, 2011
Enrollment StartJan 1, 2011
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.4 years ago

Interventions

Direct-to-patient tailored cardiovascular risk message systembehavioral

Patient informational mailings